Aug 5, 2018 Safety of Fentanyl REMS Questioned at FDA Advisors Meeting Safety of Fentanyl REMS Questioned at FDA Advisors MeetingSILVER SPRING, Md. -- There was no clear-cut decision at an FDA advisory committee meeting Friday about whether the Risk Evaluation and ... read morePublished on 2018-08-05